This focused issue on “Interventional Oncology” is edited by
- David C. Madoff, MD, Yale School of Medicine, New Haven, CT USA;
- Julius Chapiro, MD, Yale School of Medicine, New Haven, CT USA; and
- Uei Pua, MBBS, Tan Tock Seng Hospital, National University of Singapore, Singapore
This issue will highlight some of the key topics where IO therapies have had major advances including liver, lung, renal, musculoskeletal and pancreatic cancers. Furthermore, the critical roles of IO in helping referring physicians with diagnosis (e.g., biopsy), prognosis (e.g., radiomics) and palliation (e.g., pain management) of their patients will be discussed. We hope the readership of the journal will find the following articles on IO as interesting and as important to the management of their patients as we do.